About XTAGEN
A Molecular Breakthrough in Inflammation Management
Chronic inflammation is more than just pain — it’s a silent disruptor of mobility, immunity, and long-term health.
Xtagen™ is the breakthrough.
Developed in Australia and powered by Abagen™, Xtagen™ is a patented marine peptide complex that works at the molecular level to combat inflammation, restore joint function, and protect against oxidative stress.
This isn’t a generic anti-inflammatory.
Xtagen™ defines a new era in inflammation science.
From the Ocean to the Lab: The Origin of Xtagen™
Xtagen™ is built on Abagen™, a bioactive peptide matrix derived from sustainably sourced marine species — notably abalone. These peptides are naturally rich in sulphated proteins that demonstrate powerful anti-inflammatory, anticoagulant, and cytoprotective properties.
Through years of targeted R&D, this complex was stabilized, optimized, and formulated into Xtagen™ — a clinically validated, orally available inflammation therapy.
Developed in Australia. Protected by patents. Delivered globally.
Why XTAGEN™Outperforms Traditional Actives
XTAGEN™ offers multi-pathway activity, clinically validated to outperform traditional compounds like glucosamine, chondroitin, and curcumin — both in mechanism and results.
| Mechanism of Action | XTAGEN™ | Glucosamine | Chondroitin | Curcumin |
|---|---|---|---|---|
| IL-6 & TNF-α Suppression | ||||
| MAPK Pathway Inhibition | ||||
| Antioxidant Cytoprotection | ||||
| Bioavailability | High (marine peptides) | Moderate | Moderate | Low |
| Onset of Action | Rapid | Variable | Delayed | Delayed |
- Strong/clinically proven
- No known activity
- Limited/indirect evidence
XTAGEN™ has demonstrated up to 67% reduction in IL-6 and 3x improvement in synovitis scores compared to curcumin in comparative models.
Engineered for a Global Standard
XTAGEN™ is more than a formulation — it is the scientific face of ABAGEN™, backed by validated biochemical activity and global innovation standards.
Marketed exclusively by Xania Corporation USA Inc and its overseas group companies, XTAGEN™ is currently being introduced into strategic regions through exclusive, no-competition partnerships.
This ensures that partners not only access a differentiated, science-first solution — but one with protected market potential and unmatched clinical positioning.
Our Mission
To lead the global shift toward natural, clinically validated inflammation therapies — merging the intelligence of marine science with the discipline of pharmaceutical development.
Xtagen™ is here to transform the standard of care for inflammation — naturally, powerfully, and globally.
